Deal Timeline

Plotted by close date where disclosed, otherwise announcement. Select any marker to jump to the deal entry.

The Acquisition Playbook.

Three patterns run through Clarivate's acquisitions — what it looks for, how it pays, and how it folds in what it buys.

01
Acquisition criteria
Two transformational debt-and-equity-funded megadeals (CPA Global in 2020 and Pr...
Two transformational debt-and-equity-funded megadeals (CPA Global in 2020 and ProQuest in 2021) built end-to-end platforms across the IP lifecycle and the academic/research market.
PublonsKopernioTrademarkVision USASequenceBaseDarts-ip
02
Capital deployment
A steady stream of smaller IP-content tuck-ins (Darts-ip, SequenceBase, Beijing ...
A steady stream of smaller IP-content tuck-ins (Darts-ip, SequenceBase, Beijing IncoPat, Hanlim IPS, TrademarkVision, Bioinfogate) added specialized patent, trademark, case-law and drug-safety data and expanded into China and South Korea.
PublonsKopernioTrademarkVision USASequenceBaseDarts-ip
03
Integration approach
Diversification beyond scientific and IP data into life-sciences/healthcare anal...
Diversification beyond scientific and IP data into life-sciences/healthcare analytics via Decision Resources Group (2020), followed after 2021 by a pivot to deleveraging and portfolio pruning (divestitures of ScholarOne and Valipat in 2024) rather than new acquisitions.
PublonsKopernioTrademarkVision USASequenceBaseDarts-ip

The Full Deal Book

12 acquisitions — each with the deal value, financing structure, target revenue, and executive commentary where disclosed.

01 Publons Not disclosed
Announced Jun 2017 Closed Jun 2017

Acquired the researcher-facing peer-review recognition platform to increase the value of Clarivate's existing research products (later folded into Web of Science) and support researchers in the peer-review process.

On June 1, 2017, the Company acquired all assets, liabilities and equity interests of Publons Limited and its wholly-owned subsidiaries, a researcher-facing peer-review data and recognition platform.
02 Kopernio Not disclosed
Announced Mar 2018 Closed Mar 2018

Acquired the Kopernio research-access technology startup to strengthen scholarly content discovery; deal included up to $3.5 million of contingent earn-out payments through 2021.

On March 15, 2018, the Company acquired all of the outstanding stock of Kopernio ... which included $2,322 of goodwill.
03 TrademarkVision USA, LLC $20.0M
Announced Oct 2018 Closed Oct 2018

Acquired the AI image-recognition trademark-search startup (Brisbane, Australia) to bolster the CompuMark trademark clearance and protection business; consideration was $20.0M closing net cash plus a milestone-based earn-out. $20.0 million (closing cash) plus earn-out.

The total purchase price for the acquisition consisted of $20,042 in closing date net cash consideration, subject to subsequent working capital adjustments, plus potential earn-out cash payments dependent upon achievement of certain milestones.
04 SequenceBase $2.6M
Disclosed in 8-K

Purchased the key business assets of SequenceBase, an international patent sequence information provider, to expand the IP product group's patent data offerings (accounted for as an asset acquisition). $2.6 million (asset acquisition).

In September 2019, the Company purchased the key business assets of SequenceBase, an international patent sequence information provider.
05 Darts-ip $68.4M
Announced Nov 2019 Closed Nov 2019

Acquired the Brussels-based provider of global IP case-law data and analytics to expand the IP product group's legal-intelligence content for intellectual property professionals. $68.4 million (cash).

On November 27, 2019, the Company closed on the acquisition of Darts-ip, ("Darts"), a provider of global IP case law data and analytics headquartered in Brussels, Belgium. The Company acquired 100% of the voting equity interest of Darts for cash consideration.
06 Decision Resources Group (DRG) $965.0M
Announced Feb 2020 Closed Feb 2020

Acquired the healthcare data, analytics and insights provider from Piramal Enterprises to enter the life-sciences end market; consideration was $900M base cash plus adjustments and contingent stock.

The aggregate consideration paid in connection with the closing of the DRG acquisition was $964,997, comprised of $900,000 of base cash plus $6,100 of adjusted closing cash paid on the closing date and 2,895,638 of the Company's ordinary shares issued to PEL.
07 CustomersFirst Now Not disclosed
Disclosed in 8-K

Acquired key business intangible assets of CustomersFirst Now to add customer-experience/journey capabilities; consideration not separately disclosed (asset acquisition).

08 CPA Global $8,540.9M
Announced Oct 2020 Closed Oct 2020

Acquired the global IP software and tech-enabled services leader to create an end-to-end platform spanning the full IP lifecycle; deal was largely stock (218.2M shares to Redtop/Leonard Green, ~35% pro forma ownership). Announced enterprise value was ~$6.8B; SEC-reported aggregate consideration at close (net of cash) was $8.54B. $8,540.9 million (aggregate consideration; largely stock).

The aggregate consideration in connection with the closing of the CPA Global acquisition was $8,540,886, net of $102,675 cash acquired ... composed of (i) $6,565,477 from the issuance of up to 218,183,778 ordinary shares to Redtop Holdings Limited ...
09 Beijing IncoPat Technology Co., Ltd. $52.1M
Announced Oct 2020 Closed Oct 2020

Acquired the leading Chinese patent information service provider (cash on hand) as a tuck-in complementary to Clarivate's intellectual property portfolio, expanding its presence in China. $52.1 million (cash).

On October 26, 2020, the Company acquired 100% of the equity voting interest in Beijing IncoPat Technology Co., Ltd. ("IncoPat") ... The Company paid $52,133 in cash to acquire IncoPat.
10 Hanlim IPS Co., Ltd. $9.3M
Announced Nov 2020 Closed Nov 2020

Acquired the South Korean patent renewal and IP research/consulting services provider (cash on hand) to accelerate IP information and insights solutions in South Korea, complementary to Clarivate's IP portfolio. $9.3 million (cash).

On November 23, 2020, we acquired 100% of the assets, liabilities and equity interests of Hanlim IPS. Co., Ltd. ("Hanlim"), a leading patent renewal and information service provider in South Korea via cash on hand for $9,254.
11 ProQuest $4,994.3M
Announced Dec 2021 Closed Dec 2021

Acquired the global software, data and analytics provider to academic, research and national institutions from Cambridge Information Group, Atairos and other equityholders, greatly expanding the Science (Academia & Government) segment. $4,994.3 million (net of cash acquired).

The aggregate consideration in connection with the closing of the ProQuest acquisition was $4,994,334, net of $52,514 cash acquired ... composed of (i) $1,094,901 from the issuance of up to 46,910,923 ordinary shares to the Seller Group and (ii) approximately $3,951,947 in cash.
12 Bioinfogate Not disclosed
Announced Aug 2021 Closed Aug 2021

Acquired Bioinfogate (OFF-X translational drug-safety intelligence) to strengthen the life-sciences data and analytics offering; consideration not disclosed.

... Bioinfogate, which was completed in August 2021 ... the respective acquisition date of August 3, 2021 for Bioinfogate.

More Acquirer Playbooks

See how VectorShift works for your firm

Request Demo